BACKGROUND: Nonmedical use of pharmaceutical opioid analgesics (POA) increased dramatically over the past two decades and remains a major health problem in the United States, contributing to over 16 000 accidental poisoning deaths in 2010. OBJECTIVES: To create a systems-oriented theory/model to explain the historical behaviors of interest, including the various populations of nonmedical opioid users and accidental overdose mortality within those populations. To use the model to explore policy interventions including tamper-resistant drug formulations and strategies for reducing diversion of opioid medicines. METHODS: A system dynamics model was constructed to represent the population of people who initiate nonmedical POA usage. The model incorporates use trajectories including development of use disorders, transitions from reliance on informal sharing to paying for drugs, transition from oral administration to tampering to facilitate non-oral routes of administration, and transition to heroin use by some users, as well as movement into and out of the population through quitting and mortality. Empirical support was drawn from national surveys (NSDUH, TEDS, MTF, and ARCOS) and published studies. RESULTS: The model was able to replicate the patterns seen in the historical data for each user population, and the associated overdose deaths. Policy analysis showed that both tamper-resistant formulations and interventions to reduce informal sharing could significantly reduce nonmedical user populations and overdose deaths in the long term, but the modeled effect sizes require additional empirical support. CONCLUSION: Creating a theory/model that can explain system behaviors at a systems level scale is feasible and facilitates thorough evaluation of policy interventions.
BACKGROUND: Nonmedical use of pharmaceutical opioid analgesics (POA) increased dramatically over the past two decades and remains a major health problem in the United States, contributing to over 16 000 accidental poisoning deaths in 2010. OBJECTIVES: To create a systems-oriented theory/model to explain the historical behaviors of interest, including the various populations of nonmedical opioid users and accidental overdose mortality within those populations. To use the model to explore policy interventions including tamper-resistant drug formulations and strategies for reducing diversion of opioid medicines. METHODS: A system dynamics model was constructed to represent the population of people who initiate nonmedical POA usage. The model incorporates use trajectories including development of use disorders, transitions from reliance on informal sharing to paying for drugs, transition from oral administration to tampering to facilitate non-oral routes of administration, and transition to heroin use by some users, as well as movement into and out of the population through quitting and mortality. Empirical support was drawn from national surveys (NSDUH, TEDS, MTF, and ARCOS) and published studies. RESULTS: The model was able to replicate the patterns seen in the historical data for each user population, and the associated overdose deaths. Policy analysis showed that both tamper-resistant formulations and interventions to reduce informal sharing could significantly reduce nonmedical user populations and overdose deaths in the long term, but the modeled effect sizes require additional empirical support. CONCLUSION: Creating a theory/model that can explain system behaviors at a systems level scale is feasible and facilitates thorough evaluation of policy interventions.
Entities:
Keywords:
Drug take-backs; drug sharing; health policy; pharmaceutical opioids; system dynamics; tamper resistance
Authors: Wayne Wakeland; Alexandra Nielsen; Teresa D Schmidt; Dennis McCarty; Lynn R Webster; John Fitzgerald; J David Haddox Journal: Health Educ Behav Date: 2013-10
Authors: Magdalena Cerdá; Mohammad S Jalali; Ava D Hamilton; Catherine DiGennaro; Ayaz Hyder; Julian Santaella-Tenorio; Navdep Kaur; Christina Wang; Katherine M Keyes Journal: Epidemiol Rev Date: 2022-01-14 Impact factor: 6.222
Authors: Elizabeth Beaulieu; Catherine DiGennaro; Erin Stringfellow; Ava Connolly; Ava Hamilton; Ayaz Hyder; Magdalena Cerdá; Katherine M Keyes; Mohammad S Jalali Journal: Value Health Date: 2020-10-26 Impact factor: 5.725
Authors: Janetta L Iwanicki; S Geoff Severtson; Heather McDaniel; Andrew Rosenblum; Chunki Fong; Theodore J Cicero; Matthew S Ellis; Steven P Kurtz; Mance E Buttram; Richard C Dart Journal: PLoS One Date: 2016-12-09 Impact factor: 3.240
Authors: Erin S Kenzie; Elle L Parks; Erin D Bigler; Miranda M Lim; James C Chesnutt; Wayne Wakeland Journal: Front Neurol Date: 2017-09-28 Impact factor: 4.003
Authors: Erin S Kenzie; Elle L Parks; Erin D Bigler; David W Wright; Miranda M Lim; James C Chesnutt; Gregory W J Hawryluk; Wayne Gordon; Wayne Wakeland Journal: Front Neurol Date: 2018-04-04 Impact factor: 4.003
Authors: Apostolos A Alexandridis; Nabarun Dasgupta; Christopher L Ringwalt; Wayne D Rosamond; Paul R Chelminski; Stephen W Marshall Journal: PLoS One Date: 2020-01-10 Impact factor: 3.240